Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update

被引：0
|
作者：
Mooney, Kelly [1 ]
Stehr, Henning [1 ]
Kunder, Christian [2 ]
Zehnder, James [2 ]
Allison, Kimberly [2 ]
Lin, Chieh-Yu [3 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Washington Univ, Sch Med, St Louis, MO USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
216
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison of Immunohistochemistry and Fluorescence In Situ Hybridization for the Analysis of HER2/neu and Topoisomerase II-alpha Status in Human Breast Cancer
    Pala, Emel Ebru
    Zekioglu, Osman
    Ozdemir, Necmettin
    Yilmaz, Rasih
    Kapkac, Murat
    TURKISH JOURNAL OF PATHOLOGY, 2010, 26 (03) : 222 - 229
  • [32] Comparison of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for the evaluation of HER2/neu in breast cancer.
    Jacobs, TW
    Barnes, MJ
    Yaziji, H
    Gown, AM
    Schnitt, SJ
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
  • [33] Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer
    Ming Chen
    Yan Li
    Zhou Ming
    Ai Biao
    Liu Xue Zheng
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (02): : 95 - 99
  • [34] Comparison of immunohistochemistry and chromogenic in situ hybridisation for the determination of HER2 status in breast and gastric cancer.
    Shi, D.
    Zhang, G.
    Liang, X.
    Hou, J.
    Kang, S.
    Zhu, W.
    Chen, L.
    Zhou, Y.
    Li, X.
    Shao, Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S51 - S51
  • [35] Comparison of Chromogenic in Situ Hybridisation (CISH) with Immunohistochemistry (IHC) for the Detection of HER2 Status in Breast Cancer
    Desai, S.
    Shirsat, H.
    Epari, S.
    Bagal, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 659 - 660
  • [36] HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer
    Xia, Daniel
    Kuo, Frank
    Hughes, Melissa
    Lindeman, Neal
    Manning, Danielle
    Files, Janet
    Strauss, Sarah
    Kirkner, Greg
    Mohammed-Abreu, Ayesha
    Winer, Eric
    Tolaney, Sara M.
    Lin, Nancy U.
    Dillon, Deborah A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 161 (05) : 436 - 442
  • [37] HER2 status in breast carcinomas: comparison between silver in situ hybridization, chromogenic in situ hybridization and fluorescence in situ hybridization
    Ali, S. A. Md
    Nurhayati, H. M.
    Munirah, M. A.
    Reena, M. Z.
    Masir, N.
    Chandramaya, S. F.
    Rohaizak, M.
    Asmiati, A.
    Sharifah, N. A.
    Rafie, M. K.
    EJC SUPPLEMENTS, 2010, 8 (05): : 185 - 185
  • [38] Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization
    Xiu Nie
    Jun He
    Yan Li
    Dan-zhen Pan
    Hua-xiong Pan
    Mi-xia Weng
    Xiu-ping Yang
    Chun-ping Liu
    Tao Huang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33 : 379 - 384
  • [39] Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization
    Nie, Xiu
    He, Jun
    Li, Yan
    Pan, Dan-zhen
    Pan, Hua-xiong
    Weng, Mi-xia
    Yang, Xiu-ping
    Liu, Chun-ping
    Huang, Tao
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (03) : 379 - 384
  • [40] Fluorescent in situ hybridization (FISH) vs immunohistochemistry (IHC) for determination of Her2/neu status in breast cancer.
    Jimenez, RE
    Wallis, T
    Tabaczka, P
    Visscher, DW
    LABORATORY INVESTIGATION, 1999, 79 (01) : 23A - 23A
12345